OPKO Acquisitions
OPKO has acquired 10 companies and its latest acquisition was ModeX Therapeutics, Inc. on May 2022
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
ModeX Therapeutics, Inc.
May 2022
Source »$300M
ModeX is a Massachusetts-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer and infectious diseases.
Transition Therapeutics, Inc.
Jun 2016
Source »$60M
Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.
BioReference Laboratories, Inc.
Jun 2015
Source »$1.5B
BioReference is a New Jersey-based healthcare institution that provides services such as clinical laboratory testing and specimen collections for the healthcare sector.
Frequently Asked Questions about OPKO
What companies did OPKO acquire?
Companies acquired by OPKO include ModeX Therapeutics, Transition Therapeutics and BioReferenceHow many acquisitions does OPKO have?
OPKO has acquired 10 companies including ModeX Therapeutics, Transition Therapeutics and BioReference.
How many acquisitions did OPKO make in 2022?
In 2022 OPKO acquired 1 companies including ModeX Therapeutics.